← FDA Drug Approvals (Drugs@FDA)

FELBAMATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2019-05-31

Drug application

FDA Application #
ANDA211333
Application type
Abbreviated New Drug Application (Generic)
Brand name
FELBAMATE
Generic name
FELBAMATE
Active ingredients
FELBAMATE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
NOVITIUM PHARMA
Manufacturer
Novitium Pharma LLC
First approval
2019-05-31

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown